PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: <em>Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma</em>
AID  - 10.1136/jitc-2019-000391corr1
DP  - 2020 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e000391corr1
VI  - 8
IP  - 2
4099  - http://jitc.bmj.com/content/8/2/e000391corr1.short
4100  - http://jitc.bmj.com/content/8/2/e000391corr1.full
SO  - J Immunother Cancer2020 Jul 01; 8